Dmitri V Gnatenko

Title: Dmitri V Gnatenko: Innovator in Gene Therapy

Introduction

Dmitri V Gnatenko is a prominent inventor based in Port Jefferson, NY (US). He has made significant contributions to the field of gene therapy through his innovative work on hybrid adenovirus/adeno-associated virus vectors. With a total of 2 patents, his research has the potential to impact various medical applications.

Latest Patents

Gnatenko's latest patents focus on recombinant vectors that include adenovirus/adeno-associated virus (Ad/AAV) vectors and mini-adenovirus (mAd) vectors. These inventions provide cells containing these vectors and outline methods for making and using them. The compositions and methods developed by Gnatenko are particularly useful in transferring nucleotide sequences of interest into a cell, which is crucial for gene therapy applications.

Career Highlights

Dmitri V Gnatenko is affiliated with the State University of New York, where he continues to advance his research in gene therapy. His work has garnered attention for its innovative approach to vector development, which is essential for effective gene delivery systems.

Collaborations

Gnatenko has collaborated with notable colleagues, including Patrick Hearing and Wadie F Bahou. These partnerships have further enriched his research and contributed to the advancement of gene therapy technologies.

Conclusion

Dmitri V Gnatenko's contributions to the field of gene therapy through his innovative patents and collaborations highlight his role as a key inventor in this important area of research. His work continues to pave the way for advancements in medical treatments.